{"nctId":"NCT00621348","briefTitle":"Maintenance Intravenous Fluids in Children","startDateStruct":{"date":"2006-09"},"conditions":["Hyponatremia"],"count":167,"armGroups":[{"label":"Isotonic fluid group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Isotonic fluid"]},{"label":"Fluid restriction group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Hypotonic fluid"]},{"label":"Hypotonic fluid group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Hypotonic fluid"]}],"interventions":[{"name":"Isotonic fluid","otherNames":["Dextrose normal saline"]},{"name":"Hypotonic fluid","otherNames":["Hypotonic fluid,","0.2 % saline in 5 % dextrose"]},{"name":"Hypotonic fluid","otherNames":["0.2 % saline in 5% dextrose"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* All children (3 months to 12 years) who are admitted to pediatric ward or pediatric ICU, who require exclusive intravenous maintenance fluid therapy for at least 24 hours will be eligible for the study\n\nExclusion Criteria:\n\n* Children with illness that have primary fluid and electrolyte imbalance such as:\n\n  * Shock: Defined as acute circulatory failure resulting in decreased tissue perfusion and manifesting as altered sensorium, hypothermia (\\<35oC), tachycardia, prolonged capillary filling time (\\>3 seconds), hypotension (BP \\< 5th percentile for age), oliguria (\\<0.5 ml/kg/hr), hypoxemia, hyperlactatemia, requirement of fluid bolus and/ or vasopressors.\n  * Diarrhea and Dehydration: Children presenting with diarrhea and features of dehydration: lethargy, irritability and altered sensorium, thirst, decreased urine output, sunken eyes \\& dry mucous membranes, loss of skin elasticity.; children with ongoing diarrhea will be excluded even if there is no dehydration.\n  * Fluid Overload: Cirrhosis, Congestive heart failure, Acute and Chronic renal failure, Nephrotic syndrome.\n* Abnormal serum sodium or Hyperglycemia at Presentation:\n\n  * Hyponatremia : serum sodium \\< 130 mmol/L.\n  * Hypernatremia : serum sodium \\>150 mmol/L.\n  * Hyperglycemia: blood glucose \\> 180 mg/ dl.\n* Severe Protein Energy Malnutrition: Defined as grade III (50-59% of expected weight for age) and grade IV (less than 50% of expected weight for age) as per IAP classification.\n* Child who is receiving drugs which cause abnormality in serum sodium such as diuretics, vasopressin, etc.","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Months","maximumAge":"12 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence of Hyponatremia (Defined as Serum Sodium Less Than 130 mmol/L)","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Hypernatremia (Serum Sodium >150 mmol/L)","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic Hyponatremia","description":"Defined as Hyponatremia (serum sodium \\< 130 mnol/L)and presence of symptoms attributed to hyponatremia such as altered sensorium, seizure, headache, and vomiting which can not be explained otherwise.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic Hypernatremia","description":"Symptomatic hypernatremia is defined as serum sodium \\> 150 mmol/L and the presence of symptoms like altered sensorium, seizure, headache and vomiting not explained otherwise.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":58},"commonTop":["Hypernatremia"]}}}